Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Return on Capital Employed (2020 - 2024)

RAPT Therapeutics' Return on Capital Employed history spans 5 years, with the latest figure at 1.07% for Q3 2024.

  • For Q3 2024, Return on Capital Employed changed N/A year-over-year to 1.07%; the TTM value through Sep 2024 reached 1.07%, changed N/A, while the annual FY2023 figure was 0.64%, 25.0% down from the prior year.
  • Return on Capital Employed for Q3 2024 was 1.07% at RAPT Therapeutics, down from 1.02% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.3% in Q3 2021 and bottomed at 1.07% in Q3 2024.
  • The 5-year median for Return on Capital Employed is 0.41% (2023), against an average of 0.55%.
  • The largest annual shift saw Return on Capital Employed increased 15bps in 2022 before it tumbled -53bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 0.47% in 2020, then grew by 26bps to 0.35% in 2021, then fell by -10bps to 0.38% in 2022, then plummeted by -101bps to 0.77% in 2023, then plummeted by -39bps to 1.07% in 2024.
  • Per Business Quant, the three most recent readings for RAPT's Return on Capital Employed are 1.07% (Q3 2024), 1.02% (Q2 2024), and 0.89% (Q1 2024).